Skip to main content

Childhood cancers

Hepatoblastoma: childhood liver cancer, symptoms, diagnosis and treatment

Hepatoblastoma is a rare cancer of the liver that mostly affects very young children. It usually shows up as a lump or swelling in the tummy, and it is treated by specialist children's cancer teams with chemotherapy and surgery, and occasionally a liver transplant. This guide explains what it is, how it is found and staged and what treatment involves.

Last checked: 2026-10-10

Key facts

At a glance.

  • Rare

    The Children's Cancer and Leukaemia Group says about 17 children in the UK are diagnosed with hepatoblastoma each year, while the Royal Marsden gives about 10 to 15 children. Both describe it as rare.

  • Mostly very young children

    The Royal Marsden says the average age at diagnosis is one year and most cases occur before two years of age. The CCLG says it usually occurs in children under five.

  • Usually a lump in the tummy

    The Royal Marsden says hepatoblastoma usually presents as a lump in the tummy, and the CCLG adds that it can be painful.

  • AFP blood marker

    Both the CCLG and the Royal Marsden describe a protein called alpha-fetoprotein (AFP) in the blood as a tumour marker that is used to monitor response to treatment.

  • Treatment

    Treatment depends on risk group and usually includes chemotherapy and surgery, and occasionally a liver transplant.

  • Nothing a parent did

    The CCLG says it is important to remember that nothing you have done has caused your child's cancer.

What hepatoblastoma is

The Royal Marsden describes hepatoblastoma as a malignant (cancerous) tumour of the liver that usually occurs in young children. It is different from hepatocellular carcinoma, which usually occurs in adults and occasionally in older children. The Children's Cancer and Leukaemia Group (CCLG) says there are two main types of primary liver cancer in children, hepatoblastoma, which usually occurs in children under five years of age, and hepatocellular carcinoma, which is rarer in children and usually occurs in older children.

The liver is described by the CCLG as the largest organ in the body, sitting in the upper part of the tummy, larger on the right-hand side, and protected by the lower ribs. It makes proteins that help prevent too much bleeding, helps maintain fluid balance, breaks down harmful substances, converts food to energy, stores sugars and fats and produces bile. The CCLG notes that the liver is good at repairing itself and can still do its job even if only a small part of it is working, which is one reason surgery to remove part of the liver is possible.

Children with Cancer UK describes liver cancer as accounting for 1% of childhood cancers, with hepatoblastoma the most common type and more common in boys.

Causes and risk factors

The CCLG says we do not know what causes most liver tumours. The Royal Marsden says hepatoblastoma is not associated with previous hepatitis, unlike hepatocellular carcinoma, and that usually there are no associated genetic factors. It adds that there may be an increased risk in children who have a family history of familial polyposis coli, or who have a condition called Beckwith-Wiedemann syndrome.

The CCLG notes a link to increased rates of hepatoblastoma in premature and low birth weight babies. Children with Cancer UK says that a very small number of cases occur in association with congenital anomalies and familial conditions. These are associations that help researchers understand risk; they do not mean a parent could have prevented the cancer.

Symptoms

The CCLG says the most common symptom is a lump or swelling in the abdomen, which can be painful. Other possible symptoms are weight loss, loss of appetite, feeling sick and being sick. The Royal Marsden lists a lump in the tummy together with poor appetite, weight loss, lethargy, fever, vomiting and jaundice.

Many of these signs are non-specific and have common explanations in children. A persistent swelling or lump in a child's abdomen is worth showing to a GP, who can arrange an ultrasound scan and refer on if needed. If a child seems seriously unwell, use NHS 111 or emergency services.

How it is diagnosed

The CCLG says an ultrasound scan and X-rays will show if there is a tumour in the liver, and that further tests, including CT or MRI scans of the tummy and chest, are done to find out the extent of the disease, along with blood tests. The Royal Marsden lists blood samples, a chest X-ray to see if the tumour has spread to the lungs, an ultrasound to show position and size, CT or MRI of the abdomen and a CT scan of the lungs, and a biopsy, which is usually a small operation under general anaesthetic, to make the diagnosis.

Most liver tumours produce a protein called alpha-fetoprotein, or AFP. The CCLG says levels in the blood can be measured and are a useful indicator of whether the tumour is responding to treatment or may have come back, which is why AFP is called a tumour marker.

Grouping and risk

The CCLG says all liver tumours are assessed using a system called PRETEXT (pre-treatment extent of disease). It divides the liver into four areas and helps decide what kind of surgery is needed, and whether a liver transplant surgeon needs to be involved from the start. PRETEXT 1 means one liver sector is affected and the tumour can be removed with straightforward surgery, PRETEXT 2 two adjoining sectors, PRETEXT 3 two or three sectors with no two adjoining sectors free of disease, and PRETEXT 4 all four sectors, where the tumour cannot be removed without replacing the liver.

Doctors also look at whether the cancer has spread beyond the liver, into blood vessels, into the tummy or into the lungs or other organs. The CCLG says that if it spreads outside the liver it usually goes to the lungs, and about 1 in 5 children are found to have affected lungs at diagnosis. The Royal Marsden divides treatment into standard risk, where the tumour is confined to the liver and involves at most three segments, and high risk, where it involves all four segments and/or has spread outside the liver.

Treatment

The CCLG says treatment for hepatoblastoma is usually a combination of chemotherapy and surgery, and the timing of surgery and intensity of chemotherapy are decided using risk factors including grouping, whether the tumour has spread, AFP levels and the age of the child. The Royal Marsden similarly says that treatment usually includes chemotherapy and surgery, and occasionally liver transplantation.

Risk groups and treatment approach described by the CCLG
Risk groupDescriptionTypical approach
Very low riskSmall and only in the liverIt may be safe to remove the tumour at diagnosis; most children still need some chemotherapy afterwards
Low riskOnly in the liver but cannot be removed at diagnosisChemotherapy to shrink the tumour, then surgery, then usually more chemotherapy
Intermediate riskOther risk factors but usually only in the liverIntense chemotherapy first; many can have standard surgery but some need a liver transplant
High riskUsually spread outside the liverIntense chemotherapy first to clear disease outside the liver before surgery or transplant

Surgery, transplant and clinical trials

The CCLG says all children who are able will have surgery, either upfront or after chemotherapy. If the tumour involves all four sectors of the liver, a liver transplant will probably be needed, which it says is recommended for hepatoblastoma. In a transplant the whole liver is removed and replaced with a liver from another person. The family is told about this from the beginning and may be given the opportunity to think about donating half of their liver to their child, or the child may have a liver from a donor. A transplant is only possible if all the cancer outside the liver has gone.

The CCLG notes that many children have treatment as part of a clinical research trial, that taking part is voluntary and that you will be given time to decide. When no trial is available, doctors use guidelines agreed by experts across the UK.

Outlook and support

Outcomes depend on risk group and whether the tumour can be completely removed. Children with Cancer UK gives a five-year survival rate of 73% for childhood liver cancer overall, a figure for liver cancer in children as a whole rather than for hepatoblastoma alone. Your child's own team is the right source for what the outlook means for them.

A clinical nurse specialist and the wider team at a specialist children's cancer centre support families through treatment. Charities such as the CCLG and Children with Cancer UK provide information for parents, and it is worth asking your team about psychological support for the whole family.

NHS and private care in general terms

Because hepatoblastoma is so rare, it is managed by specialist children's cancer teams, with surgery carried out by a specialist liver surgeon and a transplant team involved where needed. Families sometimes seek a second opinion privately, which can sit alongside NHS care. Whichever route you use, the child's pathology, PRETEXT group and AFP results should travel with them.

Frequently asked

Questions people ask.

Quick, plain-English answers to the questions we hear most.

  • How common is hepatoblastoma?

    It is rare. The CCLG says about 17 children in the UK are diagnosed each year, and the Royal Marsden says about 10 to 15, so figures vary between sources.

  • What age does it affect?

    The Royal Marsden says the average age at diagnosis is one year and most cases occur before two years of age. The CCLG says it usually occurs in children under five.

  • What are the first signs?

    The usual first sign, according to the Royal Marsden and the CCLG, is a lump or swelling in the tummy. Poor appetite, weight loss, tiredness, fever, vomiting and jaundice can also occur.

  • Did I cause it?

    No. The CCLG says nothing you have done has caused your child's cancer, and that we do not know what causes most liver tumours.

  • What is AFP?

    Alpha-fetoprotein is a protein most liver tumours produce. The CCLG says measuring it in the blood helps show whether treatment is working or the tumour has returned.

  • What is PRETEXT?

    It is the grouping system the CCLG describes for assessing liver tumours before treatment, which divides the liver into four sectors and guides the type of surgery.

  • How is it treated?

    The CCLG says it is usually treated with chemotherapy and surgery, and the Royal Marsden adds that liver transplantation is occasionally needed.

  • Will my child need a liver transplant?

    Not usually. The CCLG says a transplant will probably be needed if the tumour involves all four sectors of the liver and cannot be removed otherwise, and it is only possible if cancer outside the liver has gone.

  • Can the liver cope with surgery?

    The CCLG says the liver is good at repairing itself and can do its job even if only a small part is working.

  • Are clinical trials offered?

    The CCLG says many children have treatment within a clinical trial, taking part is voluntary and you can withdraw at any stage, receiving the best standard treatment instead.

Where this comes from

Sources and checking.

This guide is for information, not medical advice.

Your GP or consultant knows your history and can tell you which parts apply to you. If your symptoms are severe, rapidly worsening, or come with red-flag features, seek urgent medical care. Figures and availability change, so treat them as a guide and confirm with the provider.

Published 2026-10-10, next review 2027-10-10.